EpimAb Biotherapeutics is Granted US Patent on Core Bispecific Antibody Technology – Yahoo Finance

EpimAb Biotherapeutics is Granted US Patent on Core Bispecific Antibody Technology  Yahoo Finance

EpimAb Biotherapeutics, an emerging biopharmaceutical company based in Shanghai, announced today that the United States Patent and Trademark Office …